Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-016-4 | CAS number: 64683-40-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- This skin sensitisation study was carried out in 1989-1990, before the entry into force of REACH regulation and the amendments of Annex VII.
Test material
- Reference substance name:
- Disodium 7-amino-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate
- EC Number:
- 228-589-1
- EC Name:
- Disodium 7-amino-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate
- Cas Number:
- 6300-50-1
- Molecular formula:
- C22H17N5O7S2.2Na
- IUPAC Name:
- disodium 7-amino-4-hydroxy-3-({4-[(4-sulfonatophenyl)diazenyl]phenyl}diazenyl)naphthalene-2-sulfonate
- Test material form:
- solid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd., Wolferstrasse 4, CH-4414 Fullinsdorf
- Females (if applicable) nulliparous and non-pregnant: not specified
- Microbiological status of animals, when known: not specified in the report
- Age at study initiation: 8 weeks
- Weight at study initiation: 367-408 g
- Housing: Individually in Makrolon type-3 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz).
- Diet (e.g. ad libitum): Pelleted standard Kliba 342, Batches 54/89 and 55/89 guinea pig breeding/ maintenance diet ("Kliba", Klingentalmuhle AG, CH-4303 Kaiseraugst) ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen, ad libitum
- Acclimation period: One week under test conditions after veterinary examination.
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+-3 (hourly monitored environment)
- Humidity (%): relative humidity 40-70 %
- Air changes (per hr): Air-conditioned with 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light/12 hours dark, music/light period
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 5%, 3%, 1%
- Day(s)/duration:
- 1
- Adequacy of induction:
- other: preliminary study
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 25%, 15%, 10%, 5%
- Day(s)/duration:
- 1 (exposure) + 2 (observation)
- Adequacy of induction:
- other: preliminary study
- Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 5% test article
- Adequacy of induction:
- other: main study
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 15% test material
- Day(s)/duration:
- Application one week after the injections. 1 day (exposure) + 2 days (observation after exposure)
- Adequacy of induction:
- other: main study
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 10%
- Day(s)/duration:
- The test and control guinea-pigs were challenged two weeks after the epidermal induction application. 1 day (exposure) + 2 days (observation)
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 females for the control group and 20 females for the test group
- Details on study design:
- RANGE FINDING TESTS:
The objective of this investigation was to identify irritant test article concentrations suitable for the induction phase of the main study. In addition, a suitable non-irritant concentration of the test article, by the topical route of administration, was identified for the challenge application.
The procedure applied for these investigations was as follows:
Intradermal injections:
Intradermal injections (0.1 ml/site) were made into the clipped flank of two guinea-pigs at concentrations of 5%, 3% and 1% of the test article in physiological saline. The resulting dermal reactions were assessed 24 hours later.
Epidermal applications:
Patches of filter paper ( 2 x 2 cm) were saturated with concentrations of 25%, 15%, 10% and 5% of the test article in physiological saline and applied to the clipped and shaved flanks of each of four guinea-pigs. The patches were covered by a strip of aluminum foil and firmly secured by elastic plaster wound round the trunk and covered with impervious adhesive tape. This procedure ensured intensive contact of the test article with the guinea pig skin. The dressings were removed after an exposure period of 24 hours and the reaction sites were assessed for erythema and edema on a numerical basis according to the scale described above. Further examination of the sites was performed 24 and 48 hours after removal of the dressings.
Prior to the first reading the test sites were depilated to facilitate the evaluation of a possible reaction.
The allocation of the different test sites on the animals was alternated in order to minimize site to site variation in responsiveness.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 1 week
- Test groups:
1) Freunds' complete adjuvant 50:50 with bi-distilled water.
2) The test article, diluted to 5 % with physiological saline.
3) The test article at the concentration used in (2), emulsified in a 50:50 mixture of Freunds' complete adjuvant and the vehicle used in (2).
- Control group: The animals of control group were treated similar to the animals of the test group with the omission of the test article, but on the application site 3 the control animals were treated similar to injection site 1.
- Site: right and left
- Frequency of applications: not specified
- Duration: --
- Concentrations: 5%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 1
- Exposure period: 1
- Test groups: Hair was clipped and shaved from a 5 x 5 cm area on the left and right flank of each guinea-pig. Two patches ( 2 x 2 cm) of filter paper were saturated with a) non-irritant concentration (10 % in physiological saline) of the test article and b) with the vehicle only and applied to the left (a) flank and right (b) flank respectively using the same method as for the epidermal application.
- Control group: The control animals were treated in the same way as described above.
- Site: --
- Concentrations: 10%
- Evaluation (hr after challenge): 24 and 48
- Challenge controls:
- Erythema and edema reactions
- Positive control substance(s):
- yes
- Remarks:
- Formaldehyde-solution
Results and discussion
- Positive control results:
- PROJECT 237060: Test for contact hypersensitivity in the albino guinea pig with FORMALDEHYDE-SOLUTION (HCHO). The guinea pig maximization test. Positive Control.
SUMMARY AND CONCLUSION
"Allergic Contact Dermatitis in the Guinea Pig: Identification of Contact Allergens" Magnusson B. Kligman A. M., 1970 published by C. C. Thomas, Springfield, Illinois, U. S. A.
According to the procedures used in this experiment (run during April 1989), clear positive results were observed in the HCHO treated animals after the epidermal challenge application.
POSITIVE ERYTHEMA REACTIONS AFTER THE FIRST CHALLENGE PROCEDURE:
after 24 hours, positive 6 / total 10
% positive of total 60
For the induction period a 10 % dilution of HCHO in bi-distilled water, and for the challenge procedure a 5 % dilution of HCHO was used.
According to the results observed it is considered that HCHO does possess a strong skin sensitizing (contact allergenic) potential in the guinea pig strain used (Dunkin-Hartley albino guinea pigs; DOHA KFM. Kleintierfarm Madoerin AG, CH-4414 Fuellinsdorf).
The positive control article HCHO (Formaldehyde-solution) was delivered by Fluka AG, 9470 Buchs, Switzerland (Article No. 4003 ), and the purity was described to be at least 37%.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- vehicle only
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- vehicle only
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 18
- Clinical observations:
- Females no. 383 and 387 died on day 25 of test. No toxic symptoms were evident in the guinea pigs of neither the control nor test group.
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- vehicle only
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no erythema, no oedema
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- vehicle only
- No. with + reactions:
- 0
- Total no. in group:
- 18
- Clinical observations:
- no erythema, no oedema Females no. 383 and 387 died on day 25 of test. No toxic symptoms were evident in the guinea pigs of neither the control nor test group.
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 10% with HCHO
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
SENSITIZING EFFECTS
CONTROL GROUP: No positive reactions were evident after the first challenge application neither when treated with physiological saline on the right nor when treated
with a 10% test article dilution on the left flank.
TEST GROUP: No positive reactions were evident after the first challenge application neither when treated with physiological saline on the right nor when treated with a 10% test article dilution on the left flank.
Due to the unequivocal findings observed after the first challenge, no second challenge was performed.
MORTALITY / VIABILITY: Females no. 362 and 387 died spontaneously on day 24 respectively 25 of test and female no. 383 died in extremis on day 25 of test.
MACROSCOPICAL FINDINGS: Females no. 362, 383 and 387- Lungs: not collapsed. Discoloration, dark-red.
SYMPTOMS, LOCAL
CONTROL GROUP: Application area around the injection sites 1 and 3 was found to show erythema and edema from day 2 to 4; necroses were observed from day 5 to 12; desiccation from day 13 to 15 and exfoliation from day 13 to 25 (termination of test). In addition discoloration was observed on days 23 to 25 on the first challenge application area.
TEST GROUP: Application area around the injection site 1 was found to show erythema and edema from day 2 to 4; necroses were observed from day 5 to 12; desiccation from day 12 to 15 and exfoliation from day 13 to 25 (termination of test).
Application area around the injection sites 2 and 3 was found to show edema and discoloration from day 2 to 5; further local symptoms were similar to the symptoms observed around the injection site 1 but around the injection site 2 exfoliation ended at day 24 of test. In addition discoloration was observed on epidermal induction application area from day 10 to 25 and on first challenge application area from day 23 to 25.
On day 9 of the test no observation could be performed because the animals were treated semi-occlusively.
SYMPTOMS, SYSTEMIC
After intracutaneous induction application on day 1 of test, the test animals showed red discolored urine up to day 4 of test.
Female no. 383 showed dyspnea and emaciation on day 24 of test.
No further systemic symptoms were observed during the study.
BODY WEIGHTS
The body weight gain of the remaining animals was not affected during the study.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- From the results described above no allergenic potency of the test article was concluded. The results were interpreted according to the rating of Magnusson and Kligman (1970).
According to the CLP Regulation, this test article is considered to be not a sensitizer. - Executive summary:
The purpose of this skin sensitization study was to assess the allergenic potential of the test substance when administered to the skin of albino guinea pigs.
For this purpose the Maximization-Test of B. Magnusson and A.M. Kligman (1970) was used. Ten animals (10 females) were treated as control group and twenty animals (20 females) were treated as test group.
Prior to the first challenge reading of the reactions, the skin was depilated to clean the application site from staining produced by the test article, so that the reactions (erythema) were clearly visible at that time.
Due to the unequivocal findings observed after the first challenge, no second challenge was performed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
